Sio Gene Therapies Inc.
SIOX · NASDAQ
12/31/2022 | 9/30/2022 | 6/30/2022 | 3/31/2022 | |
|---|---|---|---|---|
| Market Cap | $32 | $21 | $27 | $49 |
| - Cash | $46 | $50 | $55 | $64 |
| + Debt | $0 | $0 | $2 | $3 |
| Enterprise Value | -$14 | -$29 | -$26 | -$12 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | $0 | $0 | $0 | -$13 |
| % Margin | – | – | – | – |
| Net Income | -$3 | -$3 | -$8 | -$13 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.046 | -0.041 | -0.11 | -0.18 |
| % Growth | -13.2% | 62.9% | 38.9% | – |
| Operating Cash Flow | -$5 | -$5 | -$9 | -$18 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$5 | -$5 | -$9 | -$18 |